TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Average DBP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-h urinary potassium excretion increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified Medical Research Council Dyspnea Scale (mMRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of interleukin-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of bacterial levels (Porphyromonas gingivalis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: oxidation of l-[1-13C] phenylalanine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Freedom from oxygenator change at 15 days
Endpoint domain: Adverse events/effects
Primary endpoint: improvement of rhinoconjunctivitis outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower birthweight of first child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced risk of pre‐eclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: musculoskeletal-related attrition
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: all-cause attrition
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of lower extremity stress fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cardiovascular death or worsening HF
Endpoint domain: Mortality/survival
Primary endpoint: Residents' positions changed for at least 1 minute (PEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shorter‐duration movements (TEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to videogame treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Healthy Eating Index 2015 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary energy density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight fluctuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-Treatment-Discontinuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of anesthesia recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median time to primary endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average satisfaction score with the immersive 3D interactive video program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative nausea (PON)
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of serum/plasma IgA antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maternal Attachment Score (MAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum Depression Score (EPDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in serum TARC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in plasma eotaxin-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum total IgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum periostin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: normal blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in global health status scores (FACT-M)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in global health status scores (EORTC QLQ-C30)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: wound recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower dietary GHGE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of MRM pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of uremic retention solutes in serum or feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of transactional sex
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Pain reduction with osmotic dilator insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased satisfaction with care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: better clinical care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (RQLQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sleep Quality (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Effective Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Kaplan-Meier survival proportion at 6 years
Endpoint domain: Mortality/survival
Primary endpoint: Mean CBL (Crestal Bone Level)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of correct responses
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sleep duration <6 hours
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Habitual snoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Recurrence of BV
Endpoint domain: Mortality/survival
Primary endpoint: Rates of survival without BV
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of resistant isolates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Naming errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error severity ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worsening glycemic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma levels of mature PCSK9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of furin-cleaved PCSK9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of Lp(a)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient self-sufficiency
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative best-corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: combined endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Misdiagnosis rate of clinical diagnosis in diabetes
Endpoint domain: Adverse events/effects
Primary endpoint: ADHD‐RS‐IV‐PS‐TS change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MALE (Major Adverse Limb Events)
Endpoint domain: Mortality/survival
Primary endpoint: Cholesterol concentrations in human milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Completion of MIST-VR tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived difficulty of training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Liking the Blackbox training
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: calories ordered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: dietary autonomy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 6-min walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 30-s chair stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pain during sporting activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in tendon structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: functional limitation in daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postural sway metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate response on medicine use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I-CUTE scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent of excess oxycodone tablets
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: reachable workspace
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Extremity Fugl-Meyer score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of SNF472 in ulcerated calciphylaxis lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of SNF472
Endpoint domain: Adverse events/effects
Primary endpoint: CA-125 reduction (≥90%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial function (FMD%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sensitivity for predicting RMPP‐5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved mental health quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Relative abundance of Akkermansia muciniphila
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Firmicutes to Bacteroidetes ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of Rikenellaceae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatty Liver Index (FLI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effectiveness of financial incentive-based mobile health intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma Control Questionnaire (ACQ) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: obliteration of the great saphenous vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: venous disability scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cumulative incidence of ESRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of root damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of periodontal ligament (PDL) injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fiber intake (g/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HEI whole grain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HEI total improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T_max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slope_max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F_max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variation in psychopathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variation in depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variation in well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean/Cold nominations
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Not Nice nominations
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Procedural satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical performance (estimated VO2 max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working memory (DSB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: success of recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: satisfaction with interventions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: use of pain management strategies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in PSWQ score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACQ7 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nonrestorative sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: FeNO measurements postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of eosinophils in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Respiratory lung mechanics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Stimulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Minimum V95%iCTVtotal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obturation skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in glycemia after fasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence percentile score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Itch-Reported Outcome (Observer) treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Multidimensional Fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Family Impact score
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Adherence to contraceptive methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for contraceptive delivery mode
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Postoperative visual acuity in LogMAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients alive without distant metastasis
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in LARS category
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: time-to-exhaustion performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total nonesterified fatty acid (NEFA) AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Grade 3-4 and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive performance on AVLT word recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response times on Go/No-Go task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-meal glucose and insulin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BAL total protein concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma angiopoietin‐2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SEGUE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of hypermagnesemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Electrolyte and metabolic outcomes
Primary endpoint: Students' awareness related to the undesirable effects of smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMP-2 levels after 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMP-9 levels after 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemoglobin A1c (HbA1c) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: subcutaneous fat area of abdomen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Naloxone dispensing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SLR test score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with hospital-provided garments
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Exposure-related stress and/or anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: plasma protein fractional synthesis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of poor hematopoietic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HSV-2 incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: CSF levels of T-tau
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF levels of p-tau181
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive-motor tasks performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean choroidal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pachychoroid pigment epitheliopathy (PPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCC thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in % ECL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: roxadustat dose required to maintain target hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment for all risks combined
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Advice for all applicable risks combined
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Offer of referral to applicable telephone services combined
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in overall quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Referral justification
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Report findings considered abnormal and of clinical relevance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in peak pruritus score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Child literacy levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tacrolimus IPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of grade ≥ 2 CID
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: frequency of watery diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: NfH levels at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NfH levels at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NfL levels at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NfL levels at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: therapeutic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cause-specific cumulative incidence of recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Overall final retinal attachment at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of MB66 film in providing protection against HIV and HSV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Markers of arterial stiffness (AIx75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial perfusion (DPTI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distance walked
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning